{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"HOOKIPA Pharma Inc."},"Symbol":{"label":"Symbol","value":"HOOK"},"Address":{"label":"Address","value":"350 FIFTH AVENUE,72ND FLOOR, SUITE 7240, NEW YORK, New York, 10118, United States"},"Phone":{"label":"Phone","value":"+1 431 890-6360"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies."},"CompanyUrl":{"label":"Company Url","value":"https://www.hookipapharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Klaus Orlinger","title":"Chief Scientific Officer"},{"name":"Malte Peters","title":"Chief Executive Officer & Director"},{"name":"Roman Necina","title":"Chief Operations Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}